Find the Perfect Plan for Your Investment Journey
N
Latest price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €171.70M |
EV | €113.69M |
Shares Outstanding | 63.83M |
Beta | 0.60 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €2.90 |
P/E 2025E | - |
P/Revenue 2025E | 33.08x |
Revenue | 27.90% |
EPS | -2.40% |
Operating Cash Flow | -42.90% |
Free Cash Flow | -32.50% |
Revenue | 44.30% |
EPS | 8.80% |
Operating Cash Flow | -0.40% |
Free Cash Flow | -1.80% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -313.46% |
ROE 2025E | -21.40% |
ROCE 2024 | -19.38% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
N
Nightingale Health Oyj
HEALTH
Sector
Industry
CEO
Suna, Teemu
Employees
94
Website
nightingalehealth.comIPO Date
Headquarters
Mannerheimintie 164a, Helsinki, Uusimaa, 00300, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved